Support for the Severnside Alliance for Translational Research (SARTRE) - Bristol
Lead Research Organisation:
University of Bristol
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
Cardiff and Bristol Universities were awarded £1,294K to support underpinning the newly formed strategic alliance, the Severnside Alliance for Translational Research (SARTRE). The alliance represents an innovative approach towards translational research.
Organisations
- University of Bristol (Lead Research Organisation)
- University Hospital of Wales (Collaboration)
- Randox Laboratories (Collaboration)
- PUBLIC HEALTH ENGLAND (Collaboration)
- Magna Parva (Collaboration)
- Atlas Genetics (Collaboration)
- UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST (Collaboration)
- University of Kyoto (Collaboration)
- UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST (Collaboration)
- UNIVERSITY OF EXETER (Collaboration)
- Chelsea Technologies Group (Collaboration)
- Nottingham Trent University (Collaboration)
- Cardiff University (Collaboration)
- University of Bath (Collaboration)
- Shionogi & Co., Ltd. (Collaboration)
- The Gwent Group (Collaboration)
- Bristol Heart Institute (Collaboration)
- University of Bristol (Collaboration)
People |
ORCID iD |
Publications
Shoemark D
(2014)
Design and Nuclear Magnetic Resonance (NMR) Structure Determination of the Second Extracellular Immunoglobulin Tyrosine Kinase A (TrkAIg2) Domain Construct for Binding Site Elucidation in Drug Discovery
in Journal of Medicinal Chemistry
Palmer AM
(2013)
Translational medicines research.
in Drug discovery today
| Description | AF2 Teaching Module - Translational Research - Bristol |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Description | Bristol Heart Institute Steering Group |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Bristol Research Innovation Group for Health - Innovation Working Group |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Chair West of England academic Health sceiences Network Task and Finsh group submitting recommendation to the board on wealth creation within the NHS |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Clinical Research Facility Steering Group - Cardiff University |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Good Practice in Clinical Research |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Description | Innova-health white paper submitted to the competitivness council of the European Commission |
| Geographic Reach | Asia |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Institute of Bio-Sensing Technology Steering Group |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | MRes Postgraduate Training Course - Cardiff |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Description | NISCHR Industry Task and Finish Group |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | Report on best practice in traanslational research |
| Geographic Reach | National |
| Policy Influence Type | Citation in other policy documents |
| Description | SouthWest Biomedical iNets Board |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Commissioned Report - Best Practice in Translational Research |
| Amount | £50,000 (GBP) |
| Organisation | Health and Care Research Wales |
| Sector | Public |
| Country | United Kingdom |
| Start | |
| Description | DPFS Devolved Portfolio |
| Amount | £2,000,000 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | |
| Description | DPFS Resources- A Core Protein Production Facility |
| Amount | £429,787 (GBP) |
| Funding ID | G0801676 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | |
| Description | Fast forward |
| Amount | £65,000 (GBP) |
| Organisation | Intellectual Property Office (IPO) |
| Sector | Public |
| Country | United Kingdom |
| Start | |
| Description | ISSF |
| Amount | £750,000 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | |
| Description | NISCHR Imaging Fellowship |
| Amount | £138,516 (GBP) |
| Funding ID | RCUS172 |
| Organisation | Health and Care Research Wales |
| Sector | Public |
| Country | United Kingdom |
| Start | |
| Description | Protein Production Facility |
| Amount | £498,024 (GBP) |
| Funding ID | GO801676 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | |
| Description | Translational Imaging Post - Senior Lectureship |
| Amount | £138,516 (GBP) |
| Organisation | Health and Care Research Wales |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2009 |
| End | 12/2011 |
| Description | Wellcome ISSF |
| Amount | £200,000 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | |
| Description | epsrc bridging the gaps |
| Amount | £100,000 (GBP) |
| Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | |
| Title | An increase in strategic awareness of translational research |
| Description | The research material produced by SARTRE has been in the form of institutional and Welsh Government advisory documents. |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2009 |
| Provided To Others? | Yes |
| Impact | Research theme strategy has evolved to include a translational research agenda. |
| Title | Podocyte cell lines |
| Description | Human podocyte cell line |
| Type Of Material | Cell line |
| Year Produced | 2010 |
| Provided To Others? | Yes |
| Impact | We licemsed this to Shionogi for 50K could not find anywhere else to put this info. |
| Title | www.sartre.ac.uk - Website with Members Section |
| Description | Our Website allows participants in translational research to register as SARTRE Members. Data collected with the purpose of building a network of researchers across disciplines and therapeutic areas, across universities , health trusts, and industry. Available technologies and potential resources to share are asked for, as well as research interests etc. |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2010 |
| Provided To Others? | Yes |
| Impact | The provision of research material at translational network meetings enables the discussion of research themes, introduction of translational partners (e.g. lab scientist seeking clinical research partner). |
| Description | A Prototype, Graphene-Based, Electrochemical Sensor for Sepsis Biomarkers |
| Organisation | University of Bath |
| Department | Department of Chemistry |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - The team has developed a prototype, graphene-based, electrochemical sensor for the sepsis biomarker procalcitonin (PCT). - The work has in part led to the provision of 6 months of PDRA funding from Exeter for continued collaboration with Bath (Toby Jenkins and Frank Marken) to examine the develop the surface modification of graphene for electrochemical sensing purposes. - They have also discussed the work with Professor Paul O'Shea at Nottingham and have passed to him some samples of nanoparticle-decorated graphene for "SPR-imaging". There is great promise of a profitable link in the biosensing area here. - Presentation at the Great Western Electrochemistry meeting at Bath University on June 18th. - Presentation at the VBST Joint Seminar event at the Austrian Institute of Technology on June 20th. |
| Start Year | 2012 |
| Description | A Prototype, Graphene-Based, Electrochemical Sensor for Sepsis Biomarkers |
| Organisation | University of Exeter |
| Department | Physics and Astronomy |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - The team has developed a prototype, graphene-based, electrochemical sensor for the sepsis biomarker procalcitonin (PCT). - The work has in part led to the provision of 6 months of PDRA funding from Exeter for continued collaboration with Bath (Toby Jenkins and Frank Marken) to examine the develop the surface modification of graphene for electrochemical sensing purposes. - They have also discussed the work with Professor Paul O'Shea at Nottingham and have passed to him some samples of nanoparticle-decorated graphene for "SPR-imaging". There is great promise of a profitable link in the biosensing area here. - Presentation at the Great Western Electrochemistry meeting at Bath University on June 18th. - Presentation at the VBST Joint Seminar event at the Austrian Institute of Technology on June 20th. |
| Start Year | 2012 |
| Description | Bio-E Initiative |
| Organisation | Cardiff University |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Bio-E aims to foster increased cross collaborative research in medical technologies aiming to translate innovative research in material sciences and engineering towards bio-medical applications. The project is also specifically aimed at encouraging cooperation across universities. This initiative fits well with the goals of SARTRE to promote multidisciplinary translational research across universities. SARTRE Team instigated the initiative and provides the point of contact and administration for the 4 institutions. |
| Collaborator Contribution | The University of Bristol, Bath, Cardiff and Exeter contributed institutional funds to run and internal funding call to promote cross disciplinary and cross institutional collaboration. |
| Impact | - Confidentiality agreements have been signed by four Universities participating in the initiative. - Two networking events (November 2011, June 2012) have taken place. - 51 applications have been received and 12 applications have been funded (total funding £368,998) - The awarded projects have created new collaborations full details are provided for each project. - The initiative is intrinsically multidisciplinary bringing together varied number of disciplines: Chemistry, Molecular Biology, Systems Biology, Nephrology, Computer Science, Physics to name a few. |
| Start Year | 2011 |
| Description | Bio-E Initiative |
| Organisation | University of Bath |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Bio-E aims to foster increased cross collaborative research in medical technologies aiming to translate innovative research in material sciences and engineering towards bio-medical applications. The project is also specifically aimed at encouraging cooperation across universities. This initiative fits well with the goals of SARTRE to promote multidisciplinary translational research across universities. SARTRE Team instigated the initiative and provides the point of contact and administration for the 4 institutions. |
| Collaborator Contribution | The University of Bristol, Bath, Cardiff and Exeter contributed institutional funds to run and internal funding call to promote cross disciplinary and cross institutional collaboration. |
| Impact | - Confidentiality agreements have been signed by four Universities participating in the initiative. - Two networking events (November 2011, June 2012) have taken place. - 51 applications have been received and 12 applications have been funded (total funding £368,998) - The awarded projects have created new collaborations full details are provided for each project. - The initiative is intrinsically multidisciplinary bringing together varied number of disciplines: Chemistry, Molecular Biology, Systems Biology, Nephrology, Computer Science, Physics to name a few. |
| Start Year | 2011 |
| Description | Bio-E Initiative |
| Organisation | University of Exeter |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Bio-E aims to foster increased cross collaborative research in medical technologies aiming to translate innovative research in material sciences and engineering towards bio-medical applications. The project is also specifically aimed at encouraging cooperation across universities. This initiative fits well with the goals of SARTRE to promote multidisciplinary translational research across universities. SARTRE Team instigated the initiative and provides the point of contact and administration for the 4 institutions. |
| Collaborator Contribution | The University of Bristol, Bath, Cardiff and Exeter contributed institutional funds to run and internal funding call to promote cross disciplinary and cross institutional collaboration. |
| Impact | - Confidentiality agreements have been signed by four Universities participating in the initiative. - Two networking events (November 2011, June 2012) have taken place. - 51 applications have been received and 12 applications have been funded (total funding £368,998) - The awarded projects have created new collaborations full details are provided for each project. - The initiative is intrinsically multidisciplinary bringing together varied number of disciplines: Chemistry, Molecular Biology, Systems Biology, Nephrology, Computer Science, Physics to name a few. |
| Start Year | 2011 |
| Description | Computer assisted analysis of ocular imaging |
| Organisation | Cardiff University |
| Department | School of Optometry and Vision Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - Successfully applied cutting edge signal processing to ultra-high resolution optical coherence tomograph - Obtained further funding from Bio-E second round |
| Start Year | 2012 |
| Description | Computer assisted analysis of ocular imaging |
| Organisation | University of Bristol |
| Department | School of Clinical Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - Successfully applied cutting edge signal processing to ultra-high resolution optical coherence tomograph - Obtained further funding from Bio-E second round |
| Start Year | 2012 |
| Description | Critical Care Alliance |
| Organisation | Atlas Genetics |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Critical Care Alliance |
| Organisation | Cardiff University |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Critical Care Alliance |
| Organisation | Chelsea Technologies Group |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Critical Care Alliance |
| Organisation | Magna Parva |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Critical Care Alliance |
| Organisation | Nottingham Trent University |
| Department | School of Science and Technology |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Critical Care Alliance |
| Organisation | Public Health England |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Critical Care Alliance |
| Organisation | Randox Laboratories |
| Country | Global |
| Sector | Private |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Critical Care Alliance |
| Organisation | The Gwent Group |
| Department | Applied Enzyme Technology |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Critical Care Alliance |
| Organisation | University Hospital of Wales |
| Country | United Kingdom |
| Sector | Hospitals |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Critical Care Alliance |
| Organisation | University Hospitals Birmingham NHS Foundation Trust |
| Department | Critical Care Medicine |
| Country | United Kingdom |
| Sector | Hospitals |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Critical Care Alliance |
| Organisation | University Hospitals Bristol NHS Foundation Trust |
| Department | Intensive Care Unit |
| Country | United Kingdom |
| Sector | Hospitals |
| PI Contribution | Support and organisation of network meetings. Joint bid preparation, consortia formation and proposals submitted to EU COST initiative, Wellcome Trust Health Innovation Challenge Fund (now at full bid stage) TSB Sepsis I and Sepsis II. Both of the latter were successful resulting in over £2M funding from TSB for the consortia. |
| Collaborator Contribution | We enabled a cross disciplinary network to be established and interacted with external partners to engage in joint activities. In the Consortia for Sepsis I and Sepsis II the Critical Care Alliance are the clinical partners providing the clinical expertise and the crucial patient access and clinical samples. |
| Impact | Interdisciplinary networking, between Clinical consultants in critical care and basic scientists in Chemistry, Pharmacy, Physics, Immunology and Biomedical Sciences. Interaction with industry and formation of consortia to apply for initiatives above. |
| Start Year | 2011 |
| Description | Development of a new platelet analyser for clinical application to be tested in adult cardiac surgery patients |
| Organisation | Bristol Heart Institute |
| Country | United Kingdom |
| Sector | Hospitals |
| PI Contribution | This collaboration came about following a Bio-E symposium which was organised by SARTRE to show case current funded projects and to call for new projects and collaborations. |
| Collaborator Contribution | SARTRE set up and part funded the Bio-E initiative between the universities of Cardiff, Bristol, Bath and Exeter. This NIHR i4i award is for £543,926 |
| Impact | Multi disciplinary - Physics, Physiology and Pharmacology, Cardiovascular science, clinical science and clinical and molecular medicine. |
| Start Year | 2013 |
| Description | Development of a new platelet analyser for clinical application to be tested in adult cardiac surgery patients |
| Organisation | University of Bristol |
| Department | School of Cellular and Molecular Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This collaboration came about following a Bio-E symposium which was organised by SARTRE to show case current funded projects and to call for new projects and collaborations. |
| Collaborator Contribution | SARTRE set up and part funded the Bio-E initiative between the universities of Cardiff, Bristol, Bath and Exeter. This NIHR i4i award is for £543,926 |
| Impact | Multi disciplinary - Physics, Physiology and Pharmacology, Cardiovascular science, clinical science and clinical and molecular medicine. |
| Start Year | 2013 |
| Description | Development of a new platelet analyser for clinical application to be tested in adult cardiac surgery patients |
| Organisation | University of Bristol |
| Department | School of Clinical Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This collaboration came about following a Bio-E symposium which was organised by SARTRE to show case current funded projects and to call for new projects and collaborations. |
| Collaborator Contribution | SARTRE set up and part funded the Bio-E initiative between the universities of Cardiff, Bristol, Bath and Exeter. This NIHR i4i award is for £543,926 |
| Impact | Multi disciplinary - Physics, Physiology and Pharmacology, Cardiovascular science, clinical science and clinical and molecular medicine. |
| Start Year | 2013 |
| Description | Development of a new platelet analyser for clinical application to be tested in adult cardiac surgery patients |
| Organisation | University of Bristol |
| Department | School of Physics |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This collaboration came about following a Bio-E symposium which was organised by SARTRE to show case current funded projects and to call for new projects and collaborations. |
| Collaborator Contribution | SARTRE set up and part funded the Bio-E initiative between the universities of Cardiff, Bristol, Bath and Exeter. This NIHR i4i award is for £543,926 |
| Impact | Multi disciplinary - Physics, Physiology and Pharmacology, Cardiovascular science, clinical science and clinical and molecular medicine. |
| Start Year | 2013 |
| Description | Development of a new platelet analyser for clinical application to be tested in adult cardiac surgery patients |
| Organisation | University of Bristol |
| Department | School of Physiology, Pharmacology and Neuroscience |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This collaboration came about following a Bio-E symposium which was organised by SARTRE to show case current funded projects and to call for new projects and collaborations. |
| Collaborator Contribution | SARTRE set up and part funded the Bio-E initiative between the universities of Cardiff, Bristol, Bath and Exeter. This NIHR i4i award is for £543,926 |
| Impact | Multi disciplinary - Physics, Physiology and Pharmacology, Cardiovascular science, clinical science and clinical and molecular medicine. |
| Start Year | 2013 |
| Description | Enhancing electrochemical DNA biosensing with active sensitisers. |
| Organisation | Cardiff University |
| Department | School of Chemistry |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - Three new DNA sensitisers based on cobalt complexes were developed showing affinities to random sequence double-stranded DNA - An abstract for presentation at the Electrochem 2012 conference was accepted and invited as a keynote talk: P. Estrela, L.C.C. Wong, E.M. Regan, A.J. Hallett, S.J.A. Pope, N.J. Buurma, "Enhancing Electrochemical DNA Biosensing with Active Sensitisers"; Dublin, 2-4 September 2012. - A responsive mode proposal is being prepared for submission to EPSRC by Autumn: S.J.A. Pope (PI), N.J. Buurma, P. Estrela, 30 months, fEC approx. £516k |
| Start Year | 2012 |
| Description | Enhancing electrochemical DNA biosensing with active sensitisers. |
| Organisation | University of Bath |
| Department | Department of Electronic and Electrical Engineering |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - Three new DNA sensitisers based on cobalt complexes were developed showing affinities to random sequence double-stranded DNA - An abstract for presentation at the Electrochem 2012 conference was accepted and invited as a keynote talk: P. Estrela, L.C.C. Wong, E.M. Regan, A.J. Hallett, S.J.A. Pope, N.J. Buurma, "Enhancing Electrochemical DNA Biosensing with Active Sensitisers"; Dublin, 2-4 September 2012. - A responsive mode proposal is being prepared for submission to EPSRC by Autumn: S.J.A. Pope (PI), N.J. Buurma, P. Estrela, 30 months, fEC approx. £516k |
| Start Year | 2012 |
| Description | Fabrication of a device for measuring Raman spectra of pharmaceutical formulations in vivo |
| Organisation | University of Bath |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - Fabrication of a device for measuring Raman spectra of pharmaceutical formulations in vivo - An MRC application has been submitted to the DPFS funding stream that has been successful at the outline stage - A patent of the model system is being filed at present |
| Start Year | 2011 |
| Description | Fabrication of a device for measuring Raman spectra of pharmaceutical formulations in vivo |
| Organisation | University of Bristol |
| Department | Materials Science |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - Fabrication of a device for measuring Raman spectra of pharmaceutical formulations in vivo - An MRC application has been submitted to the DPFS funding stream that has been successful at the outline stage - A patent of the model system is being filed at present |
| Start Year | 2011 |
| Description | Kyoto University Translational Research Centre |
| Organisation | University of Kyoto |
| Department | Translational Research Centre |
| Country | Japan |
| Sector | Academic/University |
| PI Contribution | The SARTRE Team facilitate the visits from Japan. |
| Collaborator Contribution | Ongoing discussions relate to collaborative studies with academics in Bristol and Cardiff. These discussion will lead to joint projects and funding applications. |
| Impact | MoU signed; no output yet. |
| Start Year | 2010 |
| Description | Magneto-optical endotoxin sensing in the diagnosis of sepsis |
| Organisation | Cardiff University |
| Department | School of Pharmacy and Pharmaceutical Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - Demonstrated that lipopolysaccharide (LPS) binding to magnetic nanoparticles can be detected and quantified magneto-optically. - Two PDRAs (Cardiff and Exeter) continue to work together on the project, synthesising refined materials and testing their magneto - optical properties. |
| Start Year | 2012 |
| Description | Magneto-optical endotoxin sensing in the diagnosis of sepsis |
| Organisation | University of Exeter |
| Department | College of Engineering, Mathematics & Physical Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - Demonstrated that lipopolysaccharide (LPS) binding to magnetic nanoparticles can be detected and quantified magneto-optically. - Two PDRAs (Cardiff and Exeter) continue to work together on the project, synthesising refined materials and testing their magneto - optical properties. |
| Start Year | 2012 |
| Description | Modelling Cortical responses in Photosensitive Epilepsy |
| Organisation | Cardiff University |
| Department | Division of Psychological Medicine and Clinical Neurosciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - A genetic algorithm was developed (Exeter) for estimation of the parameters of the model in the frequency domain that matched the output of MEG recordings from patients with photosensitive epilepsy and controls. The MEG recordings, already acquired as part of an Epilepsy Research UK Grant, comprises measurement of induced visual (occipital) cortex responses to static visual gratings. - The collaboration continues, a post doctoral fellow in Cardiff and a RA in Exeter are working collaboratively to complete data collection which is also part of a grant from Epilepsy Research UK, they will continue to work on the project to verify the model used, at which point the group expects to produce a high impact publication from this work. |
| Start Year | 2012 |
| Description | Modelling Cortical responses in Photosensitive Epilepsy |
| Organisation | University of Exeter |
| Department | College of Engineering, Mathematics & Physical Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - A genetic algorithm was developed (Exeter) for estimation of the parameters of the model in the frequency domain that matched the output of MEG recordings from patients with photosensitive epilepsy and controls. The MEG recordings, already acquired as part of an Epilepsy Research UK Grant, comprises measurement of induced visual (occipital) cortex responses to static visual gratings. - The collaboration continues, a post doctoral fellow in Cardiff and a RA in Exeter are working collaboratively to complete data collection which is also part of a grant from Epilepsy Research UK, they will continue to work on the project to verify the model used, at which point the group expects to produce a high impact publication from this work. |
| Start Year | 2012 |
| Description | Nonlinear plasmonic biosensing and functional imaging |
| Organisation | Cardiff University |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This collaborative award came out of the Bio-E initiative between Bath, Bristol, Cardiff and Exeter universities and pump-primed with funds from SARTRE. |
| Collaborator Contribution | This award came out of a Bio-E pilot funded project between the collaborators |
| Impact | The pilot project led to an EPSRC Award of £292,874 and is being partnered with BBI solutions. |
| Start Year | 2013 |
| Description | Nonlinear plasmonic biosensing and functional imaging |
| Organisation | University of Bristol |
| Department | School of Biochemistry Bristol |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This collaborative award came out of the Bio-E initiative between Bath, Bristol, Cardiff and Exeter universities and pump-primed with funds from SARTRE. |
| Collaborator Contribution | This award came out of a Bio-E pilot funded project between the collaborators |
| Impact | The pilot project led to an EPSRC Award of £292,874 and is being partnered with BBI solutions. |
| Start Year | 2013 |
| Description | Shionogi preferred partner |
| Organisation | Shionogi & Co., Ltd. |
| Country | Japan |
| Sector | Private |
| PI Contribution | Shionogi have preferred Uk insitutions in which to offer the Shionogi Science Programe 2011. SARTRE hosted and facilitated a discussion with Shionogi and the Universities of Bristol, Cardiff and Bath. |
| Collaborator Contribution | The other HIEs contributed as UoB. |
| Impact | N/A |
| Start Year | 2010 |
| Description | Systems biology approach to investigate the mechanism of steroid resistance in nephotic syndrome |
| Organisation | University of Bristol |
| Department | School of Clinical Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - The team develop a systems based methodology which would reproduce cellular feedback loop interactions between podocytes and epithelial cells that occur in glomerulus and investigate properties (bistability and bifurcations) of the system. - The team is planning to apply the system biology approach being developed in Exeter to other disease systems (Diabetes, Cancer, Lung disease) being studied at the School of Clinical Sciences in Bristol. - Dr Valejev regularly visits Bristol and Gavin Murphy is applying on his behalf for a visiting position at UoB |
| Start Year | 2012 |
| Description | Systems biology approach to investigate the mechanism of steroid resistance in nephotic syndrome |
| Organisation | University of Exeter |
| Department | College of Engineering, Mathematics & Physical Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This project was funded by the Bio-E initiative. SARTRE coordinated the call for projects in bioengineering. To be eligible, a project had to have collaborators in at least two institutions participating in the activity. SARTRE used a crowdsourcing model to broadcast collaborative needs to all Universities and used online and offline networking methods to promote collaborations. |
| Collaborator Contribution | Academics interested in this call attended a networking event that took place in November 2011. Also they shared their expertise via a file sharing system. The institutions participating in the initiative contributed financially to support pilot projects. |
| Impact | - The team develop a systems based methodology which would reproduce cellular feedback loop interactions between podocytes and epithelial cells that occur in glomerulus and investigate properties (bistability and bifurcations) of the system. - The team is planning to apply the system biology approach being developed in Exeter to other disease systems (Diabetes, Cancer, Lung disease) being studied at the School of Clinical Sciences in Bristol. - Dr Valejev regularly visits Bristol and Gavin Murphy is applying on his behalf for a visiting position at UoB |
| Start Year | 2012 |
| Company Name | Cotton Mouton Diagnostics Ltd. |
| Description | CMD is a South Wales start-up company spun out of the Universities of Exeter and Cardiff to exploit major business opportunities in the field of point-of-care (PoC) diagnostics. |
| Year Established | 2015 |
| Impact | TBC |
| Website | http://www.cmdiagnostics.co.uk/ |
| Description | Bio21 International conference on translational research |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Workshop Facilitator |
| Geographic Reach | International |
| Primary Audience | Other academic audiences (collaborators, peers etc.) |
| Results and Impact | Gave input to pannel discussion on best models to support Translational reseacrh Output of symposium were used in a policy paper submitted to the Austaralian research funding councils. |
| Year(s) Of Engagement Activity | 2011 |
| Description | BioWales 2010 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Health professionals |
| Results and Impact | Regional forum for biotech in Wales. Presented SARTRE and novel collaboration models with private sector Follow-up discussions |
| Year(s) Of Engagement Activity | 2010 |
| Description | BioWales 2011 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | Yes |
| Geographic Reach | Regional |
| Primary Audience | Health professionals |
| Results and Impact | Regional forum for biotech in Wales. Presented SARTRE and novel collaboration models with private sector Follow-up discussions, knowledge and awareness increase. |
| Year(s) Of Engagement Activity | 2011 |
| Description | Biomedical iNets SW |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | Local |
| Primary Audience | Health professionals |
| Results and Impact | Talk to mixed industry academia health groups in Taunton L.Sundstrom Presented ' Translating research into benefits' None |
| Year(s) Of Engagement Activity | 2011 |
| Description | British Cardiovascular Society |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | National |
| Primary Audience | Health professionals |
| Results and Impact | Presented a paper on 'Working with Industry' at their annual conference in Manchester None |
| Year(s) Of Engagement Activity | 2010 |
| Description | European Health Research Innovation Network Launch |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | L. Sundstrom gave a presentation at the launch of this new european group Title of talk was 'Working with the academic sector' Formation and launch of a new European society. |
| Year(s) Of Engagement Activity | 2011 |
| Description | First European Biomedical engineering society group meeting |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Type Of Presentation | Workshop Facilitator |
| Geographic Reach | International |
| Primary Audience | Other academic audiences (collaborators, peers etc.) |
| Results and Impact | International pannel selected to discuss the formation of a European chapter of the International society for Biomedical Engineering. L. Sundstrom was a pannelist and discussant A european branch of the BME IDEA organsiation was formed. |
| Year(s) Of Engagement Activity | 2013 |
| Description | Innova health symposium |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | Yes |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Produced Innova health White paper submitted to european competitiveness council ahead of Horizon 2020 Formally presented to European Commision by The health minister of Cyprus |
| Year(s) Of Engagement Activity | 2012 |
| URL | http://www.innovahealth.ws/ |
| Description | Internationa society for Neuropeptide research |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | National |
| Primary Audience | Other academic audiences (collaborators, peers etc.) |
| Results and Impact | International meeting in Liverpool presented paper on 'Translating research into peactice' None |
| Year(s) Of Engagement Activity | 2011 |
| Description | MITREG |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | National |
| Primary Audience | Other academic audiences (collaborators, peers etc.) |
| Results and Impact | NISCHR registered research group Microbiology infection and translational research group annual meeting Gave keynote on 'Working with Industry' None |
| Year(s) Of Engagement Activity | 2012 |
| Description | Manchesrer Industry Club |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | Local |
| Primary Audience | Other academic audiences (collaborators, peers etc.) |
| Results and Impact | Gave presentation to local industry and academic research club organised by U of Manchester talk title was 'Translating Research into benefit' None |
| Year(s) Of Engagement Activity | 2013 |
| Description | Medilink SW |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | Local |
| Primary Audience | Health professionals |
| Results and Impact | Engagement conference for SMEs L. Sundstrom presenter 'Building health science networks' none |
| Year(s) Of Engagement Activity | 2012 |
| Description | Mediwales |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | Local |
| Primary Audience | Health professionals |
| Results and Impact | Bridging academia and Industry L. Sundstrom None |
| Year(s) Of Engagement Activity | 2011 |
| Description | NISCHR AHSC Launch event |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | National |
| Primary Audience | Health professionals |
| Results and Impact | Gave a keynote on 'translating Research into Prqctise' None |
| Year(s) Of Engagement Activity | 2012 |
| Description | Nc3R |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | Yes |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | National |
| Primary Audience | Other academic audiences (collaborators, peers etc.) |
| Results and Impact | Launched crackit scheme also presented at 2 of their local road shows to support this activity Crackit scheme launched |
| Year(s) Of Engagement Activity | 2011 |
| Description | One Nucleus |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Health professionals |
| Results and Impact | Presentation in London to promote novel collaborative models between industry, academia and health providers. Follow-up discussions |
| Year(s) Of Engagement Activity | 2010 |
| Description | One nucleus (london) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | National |
| Primary Audience | Health professionals |
| Results and Impact | L. Sundstrom presenter, London 2011, 'How academia can better interact with Industry' None |
| Year(s) Of Engagement Activity | 2011 |
| Description | South East Wales Academic Health Sciences partnership launch event |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | National |
| Primary Audience | Health professionals |
| Results and Impact | L. Sundstrom presented outputs of Sartre gave paper entitles building a life sceinces ecosystem Launched Health Tech challenge pilot scheme for welsh academics to work with Health care professionals |
| Year(s) Of Engagement Activity | 2012 |
| Description | Technologies in Translational Research and Development Event |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Public/other audiences |
| Results and Impact | Translational Research and Devlopment Event - One day meeting with a mixed audience including academic, commercial, government, nhs and technology transfer professionals. Has not yet taken place |
| Year(s) Of Engagement Activity | 2010 |
| Description | Translationa research symposium |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Workshop Facilitator |
| Geographic Reach | International |
| Primary Audience | Other academic audiences (collaborators, peers etc.) |
| Results and Impact | Excange to discuss best practise with the Translational centre in Kyoto A formal Mou for collaboation bewtween Bristol University and Kyoto University People exchange bewteen Bristol and Kytoto 2 joint translational projects being developped 2013 one meber of the TR centre will join us on sbbatical for 1 yesr |
| Year(s) Of Engagement Activity | 2011 |
| Description | american association of Academic health sciences centres |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | Yes |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | International |
| Primary Audience | Health professionals |
| Results and Impact | American association of health science centres, Washington DC april 2012 L.Sundstrom J Bailey, J.Bisson, C Squire 'Translating across borders' None |
| Year(s) Of Engagement Activity | 2012 |
| Description | gatsby Foundation |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Type Of Presentation | Paper Presentation |
| Geographic Reach | National |
| Primary Audience | Health professionals |
| Results and Impact | Presented SARTRE model to an expert group Symposium was aaimed t elaborating best models for developing mental Heath research . Consultation paper circulated after meeting to various stakeholder organisations |
| Year(s) Of Engagement Activity | 2011 |